Manipur Gets its First Bone Marrow Transplant (BMT) Facility at American Oncology Institute (AOI) Imphal

Facebook
Twitter
WhatsApp

A Major Leap in Cancer Care for Manipur and Northeast India while marking the significant milestone in its journey towards providing accessible healthcare services

Imphal, 10th Mar 2025: American Oncology Institute (AOI), leading and fastest growing multi-disciplinary oncology network in South Asia, has inaugurated Manipur’s first-ever Bone Marrow Transplant (BMT) unit in collaboration with Babina Specialty Hospital in Khabeisoi, Imphal East. This state-of-the-art facility will cater not only to patients in Manipur but also to neighbouring states, significantly enhancing access to advanced hematology and oncology treatments in Northeast India. This initiative, which comes under the broader expansion plan of AOI, marking a pivotal milestone in their ongoing mission to deliver accessible and high-quality BMT services.

The inaugural event was graced by Dr Chambo Gonmei, Director of Health Services, Government of Manipur, as the Chief Guest, along with Dr N Hemantakumar, Director of Family Welfare Services, Government of Manipur, as the Guest of Honour, and Dr Dhabali Thangjam, CMD, Babina Groups, as the President of the occasion.

Dr Chambo Gonmei, Chief Guest at the event, emphasized the importance of this development, stating, “The establishment of a Bone Marrow Transplant unit in Manipur is a transformative step for healthcare in the Northeast. This will ensure timely and specialized treatment for patients battling blood cancers and other hematological conditions, reinforcing our commitment to making advanced medical care accessible within the state.”

The need for Bone Marrow Transplant programs in India has never been more critical, as BMT is a life-saving procedure for various life-threatening conditions, including leukemia, lymphoma, multiple myeloma, and aplastic anemia will now have access to world-class treatment in Imphal, eliminating the need to travel to distant metropolitan cities for transplants. Along with BMT, Nuclear Scans (Gamma Scans) and Iodine Therapy for Thyroid Cancer, which were previously only available in Guwahati, can now be accessed at AOI Imphal. This is another step forward in reducing dependence on hospitals outside the state and bringing cutting-edge cancer care to Manipur.

Highlighting the broader healthcare impact, Dr N Hemantakumar, Guest of Honour, noted, “Access to quality Cancer Care has been a challenge for many in Manipur and neighboring states. This BMT unit at AOI Imphal will drastically reduce treatment burdens on families, providing them with cutting-edge medical expertise closer to home.”

Speaking about the strategic healthcare expansion in the region, Dr Dhabali Thangjam, CMD, Babina Groups, remarked, “Babina Specialty Hospital and AOI Imphal have been at the forefront of elevating cancer treatment standards in the Northeast. This initiative is aimed at making high-quality medical treatment more affordable and accessible to people in the region. Cancer treatment should not be a privilege reserved only for those who can afford to travel to major cities.”

Harish Trivedi, CEO, CTSI-South Asia, said, “American Oncology Institute (AOI) has been at the forefront of delivering world-class Cancer Care across India. With a strong focus on innovation and patient-centric treatment, we are committed to bringing the latest advancements in oncology to regions that need them the most. Our team of highly skilled specialists continuously strives to provide cutting-edge therapies, ensuring that every patient receives the best possible care close to home. The launch of the Bone Marrow Transplant (BMT) unit at AOI Imphal is a significant milestone in our journey to revolutionize Cancer Care in the Northeast. BMT is an intensive treatment modality that requires a highly specialized team and state-of-the-art infrastructure. We are confident that this facility will be a game-changer, offering new hope and life-saving treatment to patients across Manipur and neighboring states, eliminating the need to travel far for advanced care.”

This state-of-the-art BMT unit is equipped with the latest technology, an expert multidisciplinary team, and stringent infection control measures to ensure the highest standards of patient safety and care. The launch aligns with AOI’s vision to expand its advanced oncology services across India and strengthen Cancer Care infrastructure in underserved regions. With this pioneering step, AOI Imphal is set to revolutionize cancer treatment in Manipur and the broader Northeast region, offering new hope to countless patients and their families.

Pharma Utility

Pharma Utility

Welcome to Pharma Utility, a magazine dedicated to news and services in the Indian pharmaceutical industry. Founded in the year 2007 by Mr. Digvijay Singh, in last 10 years we have moved leap and bound in making pharmacy knowledge available to all our partners.

Related Posts